HYCAMTIN, also known by its generic name topotecan, is a type of chemotherapy medication used in the treatment of various cancers, including ovarian cancer, small cell lung cancer, and certain types of cervical cancer. It belongs to a class of drugs known as topoisomerase 1 inhibitors, which work by interfering with the DNA replication process in cancer cells, thereby preventing them from dividing and growing. HYCAMTIN is typically administered through injection into a vein (intravenously) or in capsule form to be taken orally, depending on the specific type and stage of cancer being treated. As with many chemotherapy drugs, HYCAMTIN can cause side effects, which may include nausea, fatigue, hair loss, and low blood cell counts, among others. Its use and dosage are determined by a healthcare professional based on the patient's medical condition and response to treatment.